elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36245889-A7483FE4-4561-4C22-80F8-13D99E9A01C1
Q36245889-A7483FE4-4561-4C22-80F8-13D99E9A01C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36245889-A7483FE4-4561-4C22-80F8-13D99E9A01C1
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
P2860
Q36245889-A7483FE4-4561-4C22-80F8-13D99E9A01C1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36245889-A7483FE4-4561-4C22-80F8-13D99E9A01C1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
75e8e03ed50a678fb6ce5d9d060b13f9c327af41
P2860
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.